These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1233 related articles for article (PubMed ID: 26858290)

  • 21. Tree-based models for survival data with competing risks.
    Kretowska M
    Comput Methods Programs Biomed; 2018 Jun; 159():185-198. PubMed ID: 29650312
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Accounting for competing risks in randomized controlled trials: a review and recommendations for improvement.
    Austin PC; Fine JP
    Stat Med; 2017 Apr; 36(8):1203-1209. PubMed ID: 28102550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of delayed graft function on graft and patient survival in kidney transplantation: an approach using competing events analysis.
    Fonseca I; Teixeira L; Malheiro J; Martins LS; Dias L; Castro Henriques A; Mendonça D
    Transpl Int; 2015 Jun; 28(6):738-50. PubMed ID: 25689397
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cause-specific cumulative incidence estimation and the fine and gray model under both left truncation and right censoring.
    Geskus RB
    Biometrics; 2011 Mar; 67(1):39-49. PubMed ID: 20377575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel approach to examining first cardiovascular events after hypertension onset.
    Lloyd-Jones DM; Leip EP; Larson MG; Vasan RS; Levy D
    Hypertension; 2005 Jan; 45(1):39-45. PubMed ID: 15545512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Competing approaches to analysis of failure times with competing risks.
    Farley TM; Ali MM; Slaymaker E
    Stat Med; 2001 Dec; 20(23):3601-10. PubMed ID: 11746340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A competing risks analysis should report results on all cause-specific hazards and cumulative incidence functions.
    Latouche A; Allignol A; Beyersmann J; Labopin M; Fine JP
    J Clin Epidemiol; 2013 Jun; 66(6):648-53. PubMed ID: 23415868
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dealing with competing risks: testing covariates and calculating sample size.
    Pintilie M
    Stat Med; 2002 Nov; 21(22):3317-24. PubMed ID: 12407674
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Accounting for death as a competing risk in cancer-associated thrombosis studies.
    Campigotto F; Neuberg D; Zwicker JI
    Thromb Res; 2012 Apr; 129 Suppl 1():S85-7. PubMed ID: 22682141
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Competing risks analysis of patients with osteosarcoma: a comparison of four different approaches.
    Tai BC; Machin D; White I; Gebski V;
    Stat Med; 2001 Mar; 20(5):661-84. PubMed ID: 11241570
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Time-dependent covariates in the proportional subdistribution hazards model for competing risks.
    Beyersmann J; Schumacher M
    Biostatistics; 2008 Oct; 9(4):765-76. PubMed ID: 18434297
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modelling competing risks in nephrology research: an example in peritoneal dialysis.
    Teixeira L; Rodrigues A; Carvalho MJ; Cabrita A; Mendonça D
    BMC Nephrol; 2013 May; 14():110. PubMed ID: 23705871
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Statistical issues in the analysis of adverse events in time-to-event data.
    Allignol A; Beyersmann J; Schmoor C
    Pharm Stat; 2016 Jul; 15(4):297-305. PubMed ID: 26929180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Competing risk bias was common in Kaplan-Meier risk estimates published in prominent medical journals.
    van Walraven C; McAlister FA
    J Clin Epidemiol; 2016 Jan; 69():170-3.e8. PubMed ID: 26232083
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The number of primary events per variable affects estimation of the subdistribution hazard competing risks model.
    Austin PC; Allignol A; Fine JP
    J Clin Epidemiol; 2017 Mar; 83():75-84. PubMed ID: 28088594
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modelling two cause-specific hazards of competing risks in one cumulative proportional odds model?
    Ohneberg K; Schumacher M; Beyersmann J
    Stat Med; 2017 Nov; 36(27):4353-4363. PubMed ID: 28833435
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methods of competing risks analysis of end-stage renal disease and mortality among people with diabetes.
    Lim HJ; Zhang X; Dyck R; Osgood N
    BMC Med Res Methodol; 2010 Oct; 10():97. PubMed ID: 20964855
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Semiparametric accelerated failure time cure rate mixture models with competing risks.
    Choi S; Zhu L; Huang X
    Stat Med; 2018 Jan; 37(1):48-59. PubMed ID: 28983935
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Propensity-score matching with competing risks in survival analysis.
    Austin PC; Fine JP
    Stat Med; 2019 Feb; 38(5):751-777. PubMed ID: 30347461
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction of cumulative incidence function under the proportional hazards model.
    Cheng SC; Fine JP; Wei LJ
    Biometrics; 1998 Mar; 54(1):219-28. PubMed ID: 9544517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 62.